Plain-English translation of NCT06893302 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether adding —cells collected from your own bone marrow—during knee arthroscopy surgery can improve pain and function better than surgery alone. Half of the 50 participants will receive standard arthroscopic debridement surgery, and the other half will receive the same surgery plus an injection of bone marrow cells into the knee. Researchers will track your recovery over 12 months to see if the treatment group experiences better outcomes.
Currently, there isn't much high-quality research showing whether this medication actually helps patients recover better after knee surgery. This trial aims to fill that gap and give doctors clearer answers about whether adding bone marrow cells is worth doing—or whether it saves patients money and unnecessary treatment.
You likely qualify if…
You likely don't qualify if…
You will undergo arthroscopic knee surgery at Hospital for Special Surgery in New York. Before or during surgery, you'll be randomly assigned to either receive standard surgery alone or surgery plus a bone marrow cell injection (about 4 mL collected from your hip bone using a special aspiration system). After surgery, you'll complete follow-up visits and answer questions about your pain, function, and recovery over a 12-month period to help researchers understand how well the treatment works.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
United States